Aurobindo Pharma, Lupin recall drugs in US market
The USFDA has classified the action for Aurobindo Pharma as a Class II recall, and for Lupin, the health regulator classified the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon to soon expand its presence in biosimilars in US market
Dr Mazumdar Shaw, CMD, Biocon said that women must be encouraged to become entrepreneurs
Emcure launches generic Eribulin for treatment of metastatic breast cancer
The drug will be available in India at approximately 40 per cent cost of the innovator brand
Thermo Fisher Scientific partners with FSSAI
Opens advanced food safety solution centre at Ghaziabad, UP
Lupin Bioresearch Centre completes fifth successful US FDA inspection
The inspection also included review of studies done at the center’s new site at Lupin Research Park, Pune
IPA appoints Sudarshan Jain as Secretary General
Having 40 years of experience in healthcare sector, Jain has worked with top Indian and multinational companies
Packaging: Education has a roadmap
The packaging industry with a CAG at 12 per cent on a normal existing path should aim to produce over 30 million tonnes of…
Strides to launch Potassium Chloride Extended-Release tablets in the US market
Product jointly developed with Pharmaceutics International, Inc to be commercialized by Strides in the US market
2nd India SCM Leadership Summit to be held on May 16
The purpose of this summit is to meet the entire vale chain within supply chain planning, execution and management in one room at…
Lupin appoints Christine Mundkur as Independent Director
She most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc